Gilead Sciences Overview
Gilead Sciences (GILD) has a P/E ratio of 17.55, below the Healthcare sector average of 27.22.
Get informed when a big investor buys or sells
+ Follow17.55
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, GILD shows a P/E ratio of 17.55. That is below the Healthcare sector average of 27.22. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 27.22. Gilead Sciences is at 17.55, which is lower that average. That is roughly 35.5% below the sector mean. Use the comparison chart on this page to see how GILD stacks up against individual peers as well.
Investors watch GILD's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Gilead Sciences's latest reading is 17.55. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has Gilead Sciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 17.55) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 27.22, while GILD is at 17.55. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
